BioInfoBank Library


FP7 Partner
Add BioInfo.PL bioinformatics lab to Your FP7 application
bioinfo.pl

Update citations for papers by Chamberlain, JS (J S)


Title New Now Web Updated Status
Microarchitecture Is Severely Compromised but Motor Protein Function Is Preserved in Dystrophic mdx Skeletal Muscle.
 0 0 0000-00-00
Gene therapy for Duchenne muscular dystrophy: AAV leads the way.
 0 3 2009-08-16
Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
 0 0 0000-00-00
Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.
 1 0 0000-00-00
Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice.
 18 34 2010-03-16 current
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
 3 0 0000-00-00
Progress toward gene therapy of Duchenne muscular dystrophy.
 7 10 2009-11-26
Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury.
 34 51 2009-10-30
Immune evasion by muscle-specific gene expression in dystrophic muscle.
 2 0 0000-00-00
Suppression of revertant fibers in mdx mice by expression of a functional dystrophin.
 11 17 2009-11-29
Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.
 1 0 0000-00-00
Activation of JNK1 contributes to dystrophic muscle pathogenesis.
 30 45 2010-03-11 current
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
 2 0 0000-00-00
Muscular dystrophy meets the gene chip: new insights into disease pathogenesis.
 3 4 2010-01-16
Muscular dystrophy: the worm turns to genetic disease.
 0 0 0000-00-00
Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
 1 0 0000-00-00
Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice.
 49 70 2010-01-22
Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain.
 6 0 0000-00-00
Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
 18 30 2009-12-05
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.
 4 0 0000-00-00
Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.
 3 0 0000-00-00
Dystrophin mutations predict cellular susceptibility to oxidative stress.
 0 0 0000-00-00
Developments in gene therapy for muscular dystrophy.
 3 0 0000-00-00
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.
 2 0 0000-00-00
Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases.
 4 0 0000-00-00
Expression of the 71 kDa dystrophin isoform (Dp71) evaluated by gene targeting.
 9 11 2010-02-25
Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.
 3 0 0000-00-00
Characterization of dystrophin and utrophin diversity in the mouse.
 1 0 0000-00-00
An epitope structure for the C-terminal domain of dystrophin and utrophin.
 1 0 0000-00-00
Localization of Dlg at the mammalian neuromuscular junction.
 0 0 0000-00-00
mdx muscle pathology is independent of nNOS perturbation.
 4 0 0000-00-00
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
 86 145 2009-10-30
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
 12 0 0000-00-00
Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.
 2 0 0000-00-00
Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice.
 33 47 2010-03-04 current
Interactions between dystrophin and the sarcolemma membrane.
 10 23 2009-08-12
Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
 34 56 2009-09-11
The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele.
 2 0 0000-00-00
Differential expression of dystrophin isoforms in strains of mdx mice with different mutations.
 2 0 0000-00-00
Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.
 19 0 0000-00-00
Isolation of tetranucleotide repeat polymorphisms flanking the BRCA1 gene.
 1 0 2009-12-31
Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype.
 35 47 2009-09-08
Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy.
 7 0 0000-00-00
Forced expression of dystrophin deletion constructs reveals structure-function correlations.
 7 0 2010-01-02
Progress towards gene therapy for Duchenne muscular dystrophy.
 6 10 2010-03-13 current
Dlgh1, a mouse homolog of the drosophila discs-large gene, is located on chromosome 16.
 0 0 0000-00-00
Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
 7 0 0000-00-00
Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
 2 6 2010-02-03
Dinucleotide repeat polymorphism at D21S49 (21q22.3).
 1 1 2009-11-01
X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.
 13 0 0000-00-00
A B2 repeat insertion generates alternate structures of the mouse muscle gamma-phosphorylase kinase gene.
 1 0 0000-00-00
BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis.
 2 0 0000-00-00
Tetranucleotide repeat polymorphism at D17S846 maps within 40 kb of GAS at 17q12-q22.
 4 6 2009-06-26
Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
 130 208 2010-02-16
Phosphoenolpyruvate carboxykinase (GTP): characterization of the human PCK1 gene and localization distal to MODY on chromosome 20.
 15 18 2009-10-27
Deletion analysis of the dystrophin-actin binding domain.
 52 74 2010-03-02
PCR analysis of muscular dystrophy in mdx mice.
 0 0 2009-12-28
The gamma phosphorylase kinase gene, Phkg, maps to mouse chromosome 5 near Gus.
 0 0 0000-00-00
New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.
 5 0 0000-00-00
Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy.
 4 0 2010-01-09
Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.
 3 0 0000-00-00
Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.
 13 21 2009-07-29
Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.
 52 67 2010-03-13 current
Region-specific cosmids and STRPs identified by chromosome microdissection and FISH.
 3 4 2009-12-12
Characterization of 10 new polymorphic dinucleotide repeats and generation of a high-density microsatellite-based physical map of the BRCA1 region of chromosome 17q21.
 3 16 2009-09-03
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.
 120 204 2009-08-24
Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
 11 0 0000-00-00
Regulation of creatine kinase induction in differentiating mouse myoblasts.
 14 0 0000-00-00
Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts.
 39 0 2009-12-27
Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.
 5 0 0000-00-00
Expression of the murine Duchenne muscular dystrophy gene in muscle and brain.
 73 105 2009-08-08
Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.
 45 0 0000-00-00
The mouse muscle creatine kinase cDNA and deduced amino acid sequences: comparison to evolutionarily related enzymes.
 31 38 2010-01-28
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies.
 3 0 0000-00-00
Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome.
 14 20 2010-01-20
Detection of new mutation disease in man and mouse.
 1 0 0000-00-00
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.
 98 137 2010-03-15 current
Screening for steroid sulfatase (STS) gene deletions by multiplex DNA amplification.
 0 0 0000-00-00
Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy.
 9 11 2010-02-21
DXS28 (C7) maps centromeric to DXS68 (L1-4) and DXS67 (B24) by deletion analysis.
 1 0 0000-00-00
Automated genetic analysis.
 0 0 0000-00-00
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms.
 6 0 0000-00-00
Duchenne muscular dystrophy.
 0 0 2009-07-08
Expression of recombinant dystrophin and its localization to the cell membrane.
 7 0 0000-00-00
Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy.
 6 0 0000-00-00
PCR analysis of dystrophin gene mutation and expression.
 12 15 2010-03-05 current
Cross-species conservation of a polymorphic dinucleotide repeat in the dystrophin gene.
 0 0 0000-00-00
Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.
 4 0 0000-00-00
X-linked dystrophies: from gene localization to gene therapy.
 0 0 0000-00-00